ASH 2024: Rapid Uptake of Bispecific Antibodies for R/R Multiple Myeloma Observed in Community Oncology Settings

by | Dec 9, 2024 | Myeloma News | 0 comments

Source: Pharmacy Times articles

Ira Zackon, MD explains his analysis of bispecific antibody utilizaton for relapsed or refractory multiple myeloma in community oncology centers.
Read More

Submit a Comment